Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
3,522,155
-
Share change
-
+347,695
-
Total reported value
-
$806,000
-
Price per share
-
$0.24
-
Number of holders
-
31
-
Value change
-
-$17,530
-
Number of buys
-
8
-
Number of sells
-
7
Institutional Holders of SILEXION THERAPEUTICS CORP WT EXP 081529 - Stock (MACAW) as of Q1 2022
As of 31 Mar 2022,
SILEXION THERAPEUTICS CORP WT EXP 081529 - Stock (MACAW) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,522,155 shares.
The largest 10 holders included
Sage Rock Capital Management LP, Linden Advisors LP, K.J. Harrison & Partners Inc, ARISTEIA CAPITAL LLC, Periscope Capital Inc., Castle Creek Arbitrage, LLC, Kepos Capital LP, Ibex Investors LLC, Spartan Fund Management Inc., and Shaolin Capital Management LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.